Targeting brain tumours: apoferritin nanocage for delivery of novel analogues of temozolomide

Treatment for glioblastoma multiforme (GBM) consists of surgery, radiotherapy and temozolomide (TMZ) chemotherapy. Nevertheless, patient prognosis remains poor; in England 5-year survival is < 10%. Resistance to TMZ is a major obstacle thwarting successful treatment, due to overexpression of the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Bouzinab, Kaouthar, Thomas, Neil R, Turyanska, Lyudmila, Gershkovich, Pavel, Weston, Nicola, Ashford, Marianne B, Bradshaw, Tracey D
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6789696/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz167.015
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller